Xanthatin synergizes with cisplatin to suppress homologous recombination through JAK2/STAT4/BARD1 axis in human NSCLC cells.
Xanthatin synergizes with cisplatin to suppress homologous recombination through JAK2/STAT4/BARD1 axis in human NSCLC cells.
复制标题
黄嘌呤与顺铂协同抑制人非小细胞肺癌细胞JAK 2/STAT 4/BARD 1轴同源重组
DOI:
10.1111/jcmm.16271
复制
发表时间:
2021-03
影响因子:
5.3
通讯作者:
Gao Y
中科院分区:
文献类型:
--
作者:
Zhang J;Yang S;Guan H;Zhou J;Gao Y
Xanthatin (Xa) is a bicyclic sesquiterpene lactone identified from the plant Xanthium L. with impressive antitumor activity, but the role of Xa in non‐small cell lung cancer (NSCLC) is not known. Here we found that Xa inhibits proliferation, migration, invasion and induces apoptosis in NSCLC cells. RNA sequencing and Gene set enrichment analysis revealed that Xa significantly activates p53 pathway and suppresses E2F targets, G2M checkpoint and MYC targets in A549 cells. Among these changed genes, the down‐regulated gene BARD1 triggered by Xa was identified as a candidate involved in Xa’s antitumor effect because of its vital role in homologous recombination (HR). Further studies demonstrated that Xa inhibits HR through the BARD1/BRCA1/RAD51 axis, which enhances cell sensitivity to cisplatin. Mechanistic studies showed that Xa inhibits BARD1 through the JAK2/STAT4 pathway. Our study revealed that Xa is a promising drug to treat NSCLC, especially in combination with conventional chemotherapy.
登录
查看更多内容
影响因子:
11.2
作者:
Nagel ZD;Kitange GJ;Gupta SK;Joughin BA;Chaim IA;Mazzucato P;Lauffenburger DA;Sarkaria JN;Samson LD
通讯作者:
Samson LD
影响因子:
2.2
作者:
Geng, Ya-di;Zhang, Lei;Shen, Ai-Zong
通讯作者:
Shen, Ai-Zong
影响因子:
4.7
作者:
Navarra, Giovanna;Pagano, Cristina;Bifulco, Maurizio
通讯作者:
Bifulco, Maurizio
影响因子:
14.9
作者:
Krejci L;Altmannova V;Spirek M;Zhao X
通讯作者:
Zhao X
影响因子:
5.3
作者:
Liu, Man;Xiao, Cheng-qian;Yu, Qiang
通讯作者:
Yu, Qiang